Literature DB >> 19875248

[Etiopathological factors of hepatocellular carcinoma in Bangui, Central African Republic: clinical, biological characteristics and virological aspects of patients].

C Bekondi1, T Mobima, J O Ouavènè, B Koffi, X Konamna, A Béré, A Le Faou.   

Abstract

OBJECTIVES: To describe clinical, biological characteristics and virological aspects of patients with hepatocellular carcinoma (HCC). PATIENTS AND METHODS: Sera obtained from consent patients with clinical suspicion of HCC. Routine biochemical tests and serological markers of hepatitis B virus (HBV), hepatitis D virus (HDV) and hepatitis C virus (HCV) were searched. A hepatic ultrasound scan was realized and, when a suspected mass lesion was observed, ultrasonographic-guided fine needle aspiration of the hepatic mass lesion was made to ascertain the diagnosis of HCC.
RESULTS: One hundred and seventy-five sera were collected from 99 men and 76 women. Approximately 96.6% (169/175) of them had previous contact with HBV. HBs surface antigen was positive in 41% (69/169) of whom 53.6% (37/69) were co-infected by the HDV. Three patients (1.71%=3/175) were positive for anti-HCV antibodies. The other three patients (1.71%=3/175) did not present any markers for HBV or HCV. At the time of diagnosis, right upper quadrant pain, hepatomegaly, cachexia, were present in all patients. An increase in serum transaminases (70%), high bilirubin concentrations (40%), high AFP levels (40%) and low prothrombin levels (52%) were the most frequent biological abnormalities. Only 17 guided fine needle aspirations of mass lesions were realized. The diagnosis of HCC was confirmed by cytopathological examination for 14 of them.
CONCLUSIONS: HCC is a frequent pathology in the Central African Republic (CAR). According to the ultrasound imaging data, patients consult at terminal stage of the disease. This study confirms also the association between HBV and HCC in CAR. Moreover, in 26.5% of patients HDV is associated with severe forms of the disease. Copyright 2009 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19875248     DOI: 10.1016/j.patbio.2009.07.027

Source DB:  PubMed          Journal:  Pathol Biol (Paris)        ISSN: 0369-8114


  6 in total

1.  Low sero-prevalence of hepatitis delta antibodies in HIV/ hepatitis B co-infected patients attending an urban HIV clinic in Uganda.

Authors:  Elizabeth Katwesigye; Emmanuel Seremba; Fred Semitala; Ponsiano Ocama
Journal:  Afr Health Sci       Date:  2016-12       Impact factor: 0.927

2.  Epidemic history of hepatitis C virus infection in two remote communities in Nigeria, West Africa.

Authors:  Joseph C Forbi; Michael A Purdy; David S Campo; Gilberto Vaughan; Zoya E Dimitrova; Lilia M Ganova-Raeva; Guo-Liang Xia; Yury E Khudyakov
Journal:  J Gen Virol       Date:  2012-03-28       Impact factor: 3.891

3.  High Prevalence and Diversity of Hepatitis Viruses in Suspected Cases of Yellow Fever in the Democratic Republic of Congo.

Authors:  Sheila Makiala-Mandanda; Frédéric Le Gal; Nadine Ngwaka-Matsung; Steve Ahuka-Mundeke; Richard Onanga; Berthold Bivigou-Mboumba; Elisabeth Pukuta-Simbu; Athenaïs Gerber; Jessica L Abbate; Dieudonné Mwamba; Nicolas Berthet; Eric Maurice Leroy; Jean-Jacques Muyembe-Tamfum; Pierre Becquart
Journal:  J Clin Microbiol       Date:  2017-02-15       Impact factor: 5.948

4.  Determinants of undernutrition among older adults in South Gondar Zone, Ethiopia: a community-based study.

Authors:  Hiwot Yisak; Ismael Maru; Misganaw Abie; Getachew Arage; Amien Ewunetei; Melkalem Mamuye Azanaw; Fentaw Teshome
Journal:  BMJ Open       Date:  2022-01-11       Impact factor: 2.692

Review 5.  Prevalence of hepatitis D virus infection in sub-Saharan Africa: a systematic review and meta-analysis.

Authors:  Alexander J Stockdale; Mas Chaponda; Apostolos Beloukas; Richard Odame Phillips; Philippa C Matthews; Athanasios Papadimitropoulos; Simon King; Laura Bonnett; Anna Maria Geretti
Journal:  Lancet Glob Health       Date:  2017-10       Impact factor: 26.763

6.  Low sero-prevalence of hepatitis delta antibodies in HIV/ hepatitis B co-infected patients attending an urban HIV clinic in Uganda.

Authors:  Elizabeth Katwesigye; Emmanuel Seremba; Fred Semitala; Ponsiano Ocama
Journal:  Afr Health Sci       Date:  2017-12       Impact factor: 0.927

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.